Driehaus Capital Management’s Astria Therapeutics ATXS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.61M | Sell |
1,419,333
-8,884
| -0.6% | -$47.6K | 0.06% | 280 |
|
|
2025
Q1 | $7.63M | Sell |
1,428,217
-133,574
| -9% | -$713K | 0.07% | 273 |
|
|
2024
Q4 | $14M | Sell |
1,561,791
-55,837
| -3% | -$499K | 0.12% | 210 |
|
|
2024
Q3 | $17.8M | Sell |
1,617,628
-132,294
| -8% | -$1.46M | 0.15% | 185 |
|
|
2024
Q2 | $15.9M | Sell |
1,749,922
-15,057
| -0.9% | -$137K | 0.15% | 176 |
|
|
2024
Q1 | $24.8M | Buy |
1,764,979
+1,339,615
| +315% | +$18.9M | 0.25% | 120 |
|
|
2023
Q4 | $3.27M | Sell |
425,364
-1,028,840
| -71% | -$7.9M | 0.04% | 280 |
|
|
2023
Q3 | $10.8M | Sell |
1,454,204
-1,444
| -0.1% | -$10.8K | 0.14% | 196 |
|
|
2023
Q2 | $12.1M | Buy |
1,455,648
+22,974
| +2% | +$191K | 0.15% | 194 |
|
|
2023
Q1 | $19.1M | Buy |
1,432,674
+95,359
| +7% | +$1.27M | 0.27% | 124 |
|
|
2022
Q4 | $19.9M | Buy |
1,337,315
+680,954
| +104% | +$10.1M | 0.3% | 113 |
|
|
2022
Q3 | $5.93M | Buy |
+656,361
| New | +$5.93M | 0.09% | 250 |
|